KLF8 and cancer: This finding is consistent with previous studies reporting that miR-135 directly targets KLF4 (43) and its homolog KLF8 (38) and showing that miR-135 reduced cell proliferation (35), invasion, metastasis (36, 44) and increased sensitivity to chemotherapy (34) in a variety of cancer cells.